Research from the Pickart era (1970s-2000s) established that GHK-Cu influences over 4,000 human genes toward healthier expression patterns, as documented in the International Journal of Molecular Sciences and related publications
PMC6073405 BPC-157 angiogenic signaling VEGFR2-Akt-eNOS activation, nitric oxide bioavailability, FAK-paxillin cell-anchoring cascade, anti-cytokine modulation: PMC8275860 TB-4 / TB-500 G-actin sequestration and threshold-saturation mechanism actin-monomer binding, cytoskeletal mobilization for cell migration, mass-action pharmacodynamics requiring bolus dosing: PubMed 12581423 TB-4 Ac-SDKP anti-fibrotic fragment N-terminal tetrapeptide (fragment 14) released by meprin- and POP processing
Increased Intra-Abdominal, Intrathoracic, and Intracranial Pressure after Severe Brain Injury: Multiple Compartment Syndrome
Storage Store at -20C or below, protected from light and moisture
Hydroxocobalamin has relatively few major drug interactions
See our head-to-head comparison of GHK-Cu vs NAD+ for patients deciding between these two protocols for a full breakdown of where each one fits in a comprehensive longevity protocol